Looks like you clickedhttps://www.jnj.com/updated-results-of-the-spartan-study-show-25-percent-reduction-in-the-risk-of-death-in-patients-with-non-metastatic-castration-resistant-prostate-cancer-nmcrpc-treated-with-erleada-apalutamide
If you do not want to visit that page, you can close this browser tab.
